Posts by Blake Kenney

What’s New in PET/CT Influence of Biological Parameters Assessed in [18F]FDG PET/CT on Overall Survival in Cervical Cancer Patients. PET/CT Updates, Research & Education January 2020 PurposeThe aim of this study was to estimate the influence of biological parameters assessed in [F]FDG PET/CT on overall survival (OS) in cervical cancer patients.MethodsRetrospective analysis was performed on…

Happy Holidays Happy Holidays! 2019 As the holiday season is upon us, we find ourselves reflecting on the past year and those who have helped to shape our business. It’s been quite a year for us all! We hope that 2019 has been just as memorable for you, your colleagues and your loved ones. We…

What’s New in PET/CT Shared Medical Services Makes Mobile Digital PET/CT Accessible and Attainable. PET/CT Updates, Research & Education December 2019 As one of the largest providers of specialized diagnostic imaging services in the United States, we are pleased to announce we are once again leading the way in bringing the latest technologies to market.…

Shared Medical Services Introduces Mobile Digital PET/CT SMS Makes Mobile Digital PET/CT Accessible and Attainable COTTAGE GROVE, WI – November 20, 2019 – Shared Medical Services (SMS), one of the largest providers of specialized diagnostic imaging services in the United States, is pleased to announce they are once again leading the way in bringing the…

What’s New in PET/CT Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients. PET/CT Updates, Research & Education November 2019 PurposeTo investigate if early variation of PET-derived parameters after concomitant chemoradiotherapy (CRT) predicts overall survival (OS), local relapse free survival (LRFS), distant relapse free survival…

What’s New in PET/CT Metabolic and volume-based parameters of (18F)FDG PET/CT for primary mass and axillary lymph node metastasis in patients with invasive ductal carcinoma: a retrospective analysis in relation to molecular subtype, axillary lymph node metastasis and immunohistochemistry and inflammatory markers. PET/CT Updates, Research & Education October 2019 PurposeTo evaluate metabolic and volume-based parameters…

What’s New in PET/CT Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT in patients with follicular lymphoma. PET/CT Updates, Research & Education September 2019 PurposeIn the present study, we aimed to investigate the role of baseline, interim and end-of treatment positron emission tomography/computed tomography (PET/CT) in assessing the prognosis of follicular lymphoma (FL).MethodsA…

What’s New in PET/CT Prediction of lymph node metastasis by PET/CT metabolic parameters in patients with esophageal squamous cell carcinoma. PET/CT Updates, Research & Education August 2019 PurposeThe aim of this study was to investigate the capability of F-FDG PET/computed tomography (CT)-related metabolic parameters to predict lymph node metastasis (LNM) and occult lymph node metastasis…

What’s New in PET/CT Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies. PET/CT Updates, Research & Education July 2019 PurposeTo investigate the value of positron emission tomography (PET) and PET/computed tomography (CT) using fluorine-18-fluorodeoxyglucose (F-FDG) in the diagnosis, staging, restaging and…

What’s New in PET/CT Prognostic and Predictive Values of Metabolic Parameters of 18F-FDG PET/CT in Patients With Non-Small Cell Lung Cancer Treated With Chemotherapy. PET/CT Updates, Research & Education June 2019 PurposeIncreasing interests have been focused on using artificial intelligence (AI) to extend prognostic value of medical imaging. Feature extraction is a critical step for…